OKYO Pharma Limited Ordinary Shares

REPLAY BUTTONS

∣‹ ‹‹ ∥ › ›› ›∣

POSITION	OPEN	PROFIT	P & L
LONG
SHORT

OKYO Pharma Limited Ordinary Shares. Replay the stock market charts of OKYO day by day, back to 2003. Open long and short positions without spending any money.

OKYO Daily Chart

OKYO Options Chain

OKYO Pharma reports 'statistical significance' achieved in Phase 2 trial of OK-101 in dry eye disease
January 8, 2024
OKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024
January 5, 2024
OKYO Pharma on track as last patient enrolled in trial to treat dry eye disease completes final protocol visit
December 4, 2023
OKYO Pharma files IND application OK-101 to treat Neuropathic Corneal Pain
October 9, 2023
OKYO Pharma phase II dry eye trial making encouraging progress
October 5, 2023
OKYO Pharma announces share offering
September 13, 2023
OKYO Pharma completes enrollment in Phase 2 clinical trial to treat dry eye disease
September 8, 2023
OKYO Pharma dry eye disease trial reaches enrollment milestone; topline data expected by year-end
August 30, 2023
OKYO Pharma expects large enrolment in dry eye trial patients
August 15, 2023
OKYO Pharma makes good progress with flagship OK-101 drug as it wraps up its 2023 financial year
August 15, 2023

OKYO Free Cash Flow

OKYO Income Statement

OKYO Stock Price vs Net Income

OKYO Financial Reports